Chicos FAS Inc (CHS) Stock Fundamental Analysis
USA - NYSE:CHS - US1686151028 - Common Stock
7.59 USD
-0.01 (-0.13%)
7.591 USD
+0 (+0.01%)
CHS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. Both the profitability and the financial health of CHS get a neutral evaluation. Nothing too spectacular is happening here. CHS is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CHS was profitable.
CHS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHS reported negative net income in multiple years.
CHS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.82%, CHS is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
CHS has a Return On Equity of 26.40%. This is in the better half of the industry: CHS outperforms 79.84% of its industry peers.
CHS's Return On Invested Capital of 12.31% is fine compared to the rest of the industry. CHS outperforms 77.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 26.4% | ||
| ROIC | 12.31% |
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CHS's Profit Margin of 5.29% is fine compared to the rest of the industry. CHS outperforms 72.87% of its industry peers.
CHS's Profit Margin has improved in the last couple of years.
CHS's Operating Margin of 6.16% is fine compared to the rest of the industry. CHS outperforms 68.22% of its industry peers.
CHS's Operating Margin has improved in the last couple of years.
CHS's Gross Margin of 38.94% is in line compared to the rest of the industry. CHS outperforms 59.69% of its industry peers.
In the last couple of years the Gross Margin of CHS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.16% | ||
| PM (TTM) | 5.29% | ||
| GM | 38.94% |
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHS is still creating some value.
CHS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHS has less shares outstanding
The debt/assets ratio for CHS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.22 indicates that CHS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.22, CHS is in the better half of the industry, outperforming 70.54% of the companies in the same industry.
CHS has a debt to FCF ratio of 0.42. This is a very positive value and a sign of high solvency as it would only need 0.42 years to pay back of all of its debts.
The Debt to FCF ratio of CHS (0.42) is better than 82.17% of its industry peers.
CHS has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.06, CHS is doing good in the industry, outperforming 75.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.42 | ||
| Altman-Z | 3.22 |
ROIC/WACC1.34
WACC9.19%
2.3 Liquidity
A Current Ratio of 1.20 indicates that CHS should not have too much problems paying its short term obligations.
CHS has a worse Current ratio (1.20) than 72.09% of its industry peers.
CHS has a Quick Ratio of 1.20. This is a bad value and indicates that CHS is not financially healthy enough and could expect problems in meeting its short term obligations.
CHS has a worse Quick ratio (0.42) than 60.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.42 |
3. Growth
3.1 Past
The earnings per share for CHS have decreased strongly by -15.38% in the last year.
The Earnings Per Share has been growing slightly by 4.10% on average over the past years.
CHS shows a decrease in Revenue. In the last year, the revenue decreased by -0.24%.
Measured over the past years, CHS shows a decrease in Revenue. The Revenue has been decreasing by -1.26% on average per year.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
3.2 Future
CHS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.47% yearly.
CHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.60% yearly.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.86, which indicates a very decent valuation of CHS.
Based on the Price/Earnings ratio, CHS is valued a bit cheaper than 79.07% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.27. CHS is valued rather cheaply when compared to this.
CHS is valuated reasonably with a Price/Forward Earnings ratio of 10.29.
Based on the Price/Forward Earnings ratio, CHS is valued a bit cheaper than the industry average as 74.42% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.77. CHS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 10.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHS is valued cheaply inside the industry as 85.27% of the companies are valued more expensively.
67.44% of the companies in the same industry are more expensive than CHS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.37 | ||
| EV/EBITDA | 4.72 |
4.3 Compensation for Growth
CHS has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CHS's earnings are expected to decrease with -8.47% in the coming years.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CHS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.59
-0.01 (-0.13%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 10.29 | ||
| P/S | 0.44 | ||
| P/FCF | 16.37 | ||
| P/OCF | 8.25 | ||
| P/B | 2.22 | ||
| P/tB | 2.34 | ||
| EV/EBITDA | 4.72 |
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 26.4% | ||
| ROCE | 15.79% | ||
| ROIC | 12.31% | ||
| ROICexc | 14.55% | ||
| ROICexgc | 15.01% | ||
| OM | 6.16% | ||
| PM (TTM) | 5.29% | ||
| GM | 38.94% | ||
| FCFM | 2.71% |
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.42 | ||
| Debt/EBITDA | 0.14 | ||
| Cap/Depr | 134.65% | ||
| Cap/Sales | 2.67% | ||
| Interest Coverage | 35.98 | ||
| Cash Conversion | 66.14% | ||
| Profit Quality | 51.32% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.42 | ||
| Altman-Z | 3.22 |
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%